Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$495K Buy
5,890
+49
+0.8% +$3.9K 0.18% 140
2025
Q1
$524K Sell
5,841
-151
-3% -$14.1K 0.2% 133
2024
Q4
$600K Sell
5,992
-765
-11% -$78.9K 0.23% 115
2024
Q3
$767K Sell
6,757
-2,029
-23% -$241K 0.3% 93
2024
Q2
$1.09M Sell
8,786
-437
-5% -$56.3K 0.35% 78
2024
Q1
$1.22M Sell
9,223
-87
-0.9% -$10.7K 0.41% 63
2023
Q4
$1.1M Sell
9,310
-409
-4% -$42.5K 0.4% 72
2023
Q3
$976K Buy
9,719
+232
+2% +$25K 0.4% 77
2023
Q2
$1.01M Sell
9,487
-2,191
-19% -$249K 0.4% 74
2023
Q1
$1.32M Sell
11,678
-100
-0.8% -$10.8K 0.56% 54
2022
Q4
$1.21M Buy
11,778
+748
+7% +$76.5K 0.52% 57
2022
Q3
$1.02M Buy
11,030
+137
+1% +$12.2K 0.51% 55
2022
Q2
$1.03M Buy
10,893
+102
+0.9% +$9.04K 0.51% 56
2022
Q1
$885K Buy
+10,791
New +$851K 0.41% 79

Other funds holding MRK

My Legacy Advisors's MRK Position: Q2 2025 in Review

My Legacy Advisors increased its Merck (MRK) stake by 0.84% in Q2 2025, buying an estimated $3.9K and bringing the position to 5,890 shares worth $495K. The position accounts for 0.18% of the portfolio, ranked #140.

My Legacy Advisors first reported a position in MRK in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.32M in Q1 2023. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • My Legacy Advisors held 5,890 shares of Merck worth $495K as of Q2 2025.
  • My Legacy Advisors bought 49 Merck shares in Q2 2025, an estimated $3.9K.
  • Merck made up 0.18% of My Legacy Advisors's portfolio in Q2 2025, its #140 holding.
  • My Legacy Advisors first reported a position in Merck in Q1 2022 and has held it in 14 quarters since.
  • My Legacy Advisors's Merck position peaked at $1.32M in Q1 2023.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on My Legacy Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.